Christopher J. Del Nagro

Suppression of Phosphatidylinositol 3,4,5-Trisphosphate Production Is a Key Determinant of B Cell Anergy

Cecille D. Browne, Christopher J. Del Nagro, Matthew H. Cato et al. · Immunity · 2009 · 105 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

A Critical Role for Complement C3d and the B Cell Coreceptor (CD19/CD21) Complex in the Initiation of Inflammatory Arthritis

Christopher J. Del Nagro, Ravi V. Kolla, Robert C. Rickert · The Journal of Immunology · 2005 · 56 citations · Full text

Life Sciences, Immunology, Pathology +17

Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell death

Christopher J. Del Nagro, Jonathan Choi, Linda Rangell et al. · Cell Cycle · 2013 · 37 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Subcutaneous versus Intravenous Administration of Rituximab: Pharmacokinetics, CD20 Target Coverage and B-Cell Depletion in Cynomolgus Monkeys

Cheng-Ping Mao, Martin Brovarney, Karim Dabbagh et al. · PLoS ONE · 2013 · 35 citations · Full text

Pharmacy, Immunology, Pharmacokinetics +17

Multifaceted Bioanalytical Methods for the Comprehensive Pharmacokinetic and Catabolic Assessment of MEDI3726, an Anti-Prostate-Specific Membrane Antigen Pyrrolobenzodiazepine Antibody–Drug Conjugate

Yue Huang, Christopher J. Del Nagro, Kemal Balic et al. · Analytical Chemistry · 2020 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17